Detailed information for compound 874497

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 395.516 | Formula: C19H29N3O4S
  • H donors: 2 H acceptors: 4 LogP: 1.65 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(CCNC(=O)CCNS(=O)(=O)c1ccc2c(c1)CC(N2C(=O)C)C)C
  • InChi: 1S/C19H29N3O4S/c1-13(2)7-9-20-19(24)8-10-21-27(25,26)17-5-6-18-16(12-17)11-14(3)22(18)15(4)23/h5-6,12-14,21H,7-11H2,1-4H3,(H,20,24)
  • InChiKey: SEVOOSWKNBQWAH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium tuberculosis Probable oxidoreductase 0.0128 0.0551 1
Schistosoma mansoni hypothetical protein 0.1453 1 1
Trypanosoma brucei trypanothione reductase 0.005 0 0.5
Toxoplasma gondii thioredoxin reductase 0.005 0 0.5
Plasmodium falciparum thioredoxin reductase 0.005 0 0.5
Loa Loa (eye worm) hypothetical protein 0.1453 1 1
Trypanosoma cruzi trypanothione reductase, putative 0.005 0 0.5
Brugia malayi glutathione reductase 0.005 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0494 0.3164 0.3164
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0115 0.046 0.8342
Schistosoma mansoni calcium-activated potassium channel 0.0937 0.6325 0.6012
Mycobacterium tuberculosis Probable dehydrogenase 0.0115 0.046 0.8342
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0128 0.0551 1
Leishmania major trypanothione reductase 0.005 0 0.5
Mycobacterium tuberculosis Probable reductase 0.0115 0.046 0.8342
Brugia malayi Thioredoxin reductase 0.005 0 0.5
Plasmodium vivax glutathione reductase, putative 0.005 0 0.5
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0128 0.0551 1
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0128 0.0551 1
Loa Loa (eye worm) hypothetical protein 0.0443 0.2803 0.2803
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0115 0.046 0.8342
Plasmodium falciparum glutathione reductase 0.005 0 0.5
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0115 0.046 0.8342
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0115 0.046 0.8342
Echinococcus multilocularis atpase aaa+ type core atpase aaa type core 0.0863 0.5794 0.5794
Echinococcus multilocularis small conductance calcium activated potassium 0.1453 1 1
Loa Loa (eye worm) hypothetical protein 0.0467 0.2973 0.2973
Schistosoma mansoni calcium-activated potassium channel 0.1453 1 1
Plasmodium vivax thioredoxin reductase, putative 0.005 0 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.